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Neonatal pain and stress induce long-term changes in pain sensitivity and behavior.
Previously we found alterations in pain sensitivity in adolescent rats exposed to early-life
adverse events. We tested whether these alterations have long-lasting effects and if
those effects can be improved by the 5-hydroxytryptamine 1A (5-HT1A) receptor agonist
buspirone injected chronically during the adolescent period. This study investigates:
(1) effects of inflammatory pain (the injection of formalin into the pad of a hind paw) or
stress (short maternal deprivation-isolation, MI), or their combination in 1–2-day-old rats
on the adult basal pain, formalin-induced pain, anxiety and depression; (2) effects of
adolescent buspirone in adult rats that experienced similar early-life insults. Changes in
nociceptive thresholds were evaluated using the hot plate (HP) and formalin tests; levels
of anxiety and depression were assessed with the elevated plus maze and forced swim
tests respectively. Both neonatal painful and stressful treatments induced long-term
alterations in the forced swim test. Other changes in adult behavioral responses
were dependent on the type of neonatal treatment. There was a notable lack of
long-term effects of the combination of early inflammatory pain and stress of MI on
the pain responses, anxiety levels or on the effects of adolescent buspirone. This
study provides the first evidence that chronic injection of buspirone in adolescent rats
alters antinociceptive and anxiolytic effects limited to adult rats that showed behavioral
alterations induced by early-life adverse treatments. These data highlight the role of
5-HT1A receptors in long-term effects of neonatal inflammatory pain and stress of short
MI on adaptive behavior and possibility of correction of the pain and psychoemotional
behavior that were altered by adverse pain/stress intervention using buspirone during
critical adolescent period.
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INTRODUCTION
Clinical and laboratory findings indicate that early-life painful
and stressful events result in unfavorable neurodevelopmental
outcomes: adult animals demonstrate increased sensitivity to
clinical and experimental stimuli (Anand et al., 1999; Ren et al.,
2004; Grunau, 2013; Walker et al., 2016), altered function of
the hypothalamo-pituitary-adrenal axis (HPA) and behavioral
changes (Anseloni et al., 2005; Rincón-Cortés and Sullivan,
2014; Brummelte et al., 2015; Valeri et al., 2015; Victoria and
Murphy, 2016). The neonatal period is a time of neuropil
expansion, synapse formation and elevated brain plasticity,
during which the developing nervous system is characterized
by heightened sensitivity to changes in sensory experience (Rice
and Barone, 2000). Adverse consequences of pain and stress
during this critical period are crucial for brain development
and neurogenesis, the generation of new neurons and their
interrelationships, which determine normal function of the adult
brain (Leslie et al., 2011; Korosi et al., 2012).
Pain in newborn children in the neonatal intensive care unit
is accompanied by the stress of separation from the mother
(maternal deprivation). Using a rodent model of early-life
pain, we previously found disrupted adaptive behavior in
adolescent rats exposed as neonates to inflammatory pain
or stress of maternal deprivation, with the consequences of
early adverse insults dependent on the type and the age
when they occur (Butkevich et al., 2015). In the present
study, we use 1–2-day-old rats whose brain development
is similar to that of a 24-week premature human infant
(Anand et al., 1999; Schwaller and Fitzgerald, 2014). Premature
children experience significant pain from repeated therapeutic
procedures while hospitalized in the neonatal intensive care
unit (Gibbins et al., 2015). The mechanisms of long-term
influences of early-life pain and stress on nociception and
stress responses are not known and are the subject of much
clinical and basic research (Schwaller and Fitzgerald, 2014;
Brummelte et al., 2015; Victoria andMurphy, 2016;Walker et al.,
2016).
The need to understand the risks of untreated pain in
neonates and of intensive analgesic practice using opiates, which
induce long-term unfavorable effects on neuronal development,
has stimulated further research aimed at preventing the
consequences of adverse early-life events, including both
non-pharmacological (McNair et al., 2013) and pharmacological
(Walker and Yaksh, 2012) treatments of early-life pain. Our
study on the use of the 5-hydroxytryptamine 1A (5-HT1A)
receptor agonist buspirone for prevention of disorders of painful
and psycho-emotional behaviors in prenatally stressed rats
(Butkevich I. P. et al., 2011; Butkevich I. et al., 2011) suggested
that buspirone can reduce or eliminate the adverse effects of
neonatal pain and stress in the adolescent brain and improve
resilience of nociceptive functions in adulthood.
Buspirone is in clinical use as an anxiolytic that does not cause
dependance. It is also effective in the treatment of depression,
often in combination with other antidepressants due to its
molecular properties (Albert and François, 2010; Albert and
Fiori, 2014). Buspirone is a full agonist of presynaptic 5-HT1A
receptors (autoreceptors) located on the axons, soma and
dendrites of serotonergic neurons in the dorsal andmedian raphe
nuclei; activation of 5-HT1A receptors inhibits raphe firing rates
and the release of serotonin (5-HT) through a negative feedback
mechanism (Hannon and Hoyer, 2008). Buspirone is a partial
agonist of postsynaptic 5-HT1A receptors (heteroreceptors)
that present in the hippocampus, hypothalamus, thalamus and
amygdala, where these receptors are located on GABAergic
interneurons. At these postsynaptic sites, 5-HT1A receptor
activation can have an inhibitory effect on the neuronal
activity induced by various neurotransmitters. The responses
of pre- and post-synaptic 5-HT1A receptors to treatment with
antidepressants have not been adequately addressed because of
difficulties in separating effects on autoreceptors from effects on
heteroreceptors. There are different views on the involvement
of pre- and postsynaptic 5-HT1A receptors in the anxiolytic
and antidepressant effects of buspirone (Albert and Fiori, 2014).
Studies on the use of buspirone for pain relief are limited and
the results are inconsistent (Pavlakovi´c et al., 2009; Chang et al.,
2015).
Our hypothesis is that adolescent treatment with buspirone
will normalize the altered reactivity of the adult nociceptive
system that had experienced adverse events in the newborn
period. This hypothesis is supported by the finding of a period
in adolescence with heightened neurodevelopmental plasticity,
which provides opportunities to re-direct programming
stemming from neonatal life experiences (McCormick and
Green, 2013). The involvement of 5-HT1A receptor agonists
in neuroprotective effects is also known (Kline et al., 2004),
as is the ability of buspirone to increase hippocampal
neurogenesis in adult rodents (Mori et al., 2014). New data
on the anti-inflammatory properties of buspirone (Sharifi
et al., 2015) suggest its involvement in normalization of the
level of inflammatory cytokines previously altered by adverse
experiences; this contributes to restoration of afferent-efferent
connections of the raphe nuclei with the prefrontal cortex
and spinal cord which are involved in integration of the
antinociceptive and psycho-emotional systems.
The present study consists of two series of experiments.
The aim of the first was to investigate effects neonatal
inflammation-induced pain and/or stress of maternal
deprivation-isolation (MI) on adult basal pain, pain responses
to ongoing similar inflammation, and the levels of anxiety and
depression in the adult rats. The aim of the second series was
to evaluate long-term effects of chronic injections of buspirone
during adolescence on the indices of adaptive behaviors in adult




Female (n = 43) and male (n = 23) Wistar rats were obtained
from the vivarium of the I.P. Pavlov Institute of Physiology.
The animals were mated and a vaginal smear was examined
to verify insemination (Butkevich I. et al., 2011). The days
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of insemination and delivery were designated as gestational
day 0 and postnatal day 0, respectively. Pregnant rats were
initially housed four per cage and then individually after the
17th day of pregnancy. All animals were maintained under
standard conditions (12 h light, 12 h dark, lights on at
08:00) in standard plastic rat cages with food and water
available ad libitum. The birth of litters was checked twice
daily at 9 AM and 6 PM. On postnatal day one (P1) the
litters were culled to eigth pups per dam. The present study
was approved by the Animal Care and Use Committee of
the I.P. Pavlov Institute of Physiology, Russian Academy of
Sciences (St. Petersburg, Russia). Animal care was conducted in
accordance with the EC Council Directive of November 1986
(86/609/EEC).
Experimental Design
When the rats reached adult age (90 day-old male rats) the effects
of neonatal noxious insults on indices of adaptive behaviors
(basal pain in the hot plate (HP) test, inflammatory pain response
in the formalin test, psycho-emotional behaviors in the elevated
plus maze and forced swim tests) were studied (Series I). In
Series I, male rats on P1 and on P2 (P1, 2) were exposed to
the following treatments: a single injection of formalin (FOR
group) or saline (control to formalin), after which the pups
were immediately returned to their dams and siblings (n = 11,
n = 12 respectively); a single injection of FOR or saline and
immediate isolation from the dams and siblings for 60 min
(MI, ‘‘psychogenic stressor’’ (FOR followed by MI group), saline
followed by MI group, n = 9, n = 9, respectively). The formalin
concentration (2.5%), the volume of FOR or saline (0.5 µl),
the site of injection (a single subcutaneous injection into the
pad of the left hind paw) and the ‘‘psychogenic stressor’’ (each
pup placed singly in a small cage in a thermostat at 30◦C for
60 min) were similar to those in our previous work (Butkevich
et al., 2015). The injection of FOR (but not that of saline)
induced flexing and shaking of the injected paw, i.e., formalin-
induced pain behavior (licking behavior is immature in neonatal
pups). For all but three litters we tested a maximum of one
littermate from a single litter for each condition; however, in
those three litters there were 2–3 rats from each litter (three
subjects twice and two subjects once). Where there was the
more than a single rat from the same litter, the data from
the multiple pups were averaged to provide a single value
for that litter. Thus the unit of analysis was litter, a single
pup in most litters and the average of multiple pups in three
litters. In preliminary experiments we found no differences
in any of the tested parameters between adult rats treated
with saline on P1, 2 and naïve animals (not exposed to any
stimuli on P1, 2). Therefore, naïve rats were considered as
controls (CTL). Weaning was carried out on P25, and the
male rats were housed in standard cages (four per cage) until
testing on P90.
In series II and III we examined the effects of the saline
control (Series II) or buspirone (Series III) during adolescence
on the similar indices like in the Series I. In the Series III
possible favorable effects of adolescent buspirone (BUS) on the
similar behaviors altered by neonatal treatments were evaluated.
In these both series, rats were exposed to the same treatments
like in Series I on P1, 2 and then were treated in the following
experimental conditions from P25 to P39: chronic injections
(daily injections) of saline (SAL, control for buspirone) or
buspirone (buspirone hydrochloride, BUS, Sigma, 3.5 mg/kg,
1 ml i.p. at 9 AM). Buspirone exhibits its medicinal effect if
used for a long time. Thus the following groups of rats were
formed: FOR, n = 8 and n = 11; MI, n = 8 and n = 10;
FOR followed by MI, n = 9 and n = 11; CTL, n = 12 and
n = 12, for SAL (Series II) and BUS (Series III) respectively. The
buspirone dose and the duration of the treatment were from our
previous study (Butkevich I. P. et al., 2011; Butkevich I. et al.,
2011).
Adult Behavioral Tests
On P90 the rats were examined in a battery of tests conducted
in the following order: assessment of basal pain in the HP
test, of inflammatory pain in the formalin test, of anxiety
and depression in the elevated plus maze and forced swim
test respectively. The formalin test occurred the day after
the HP test, the following tests (the elevated plus maze and
the forced swim test) were performed with the interval in
3 days. The experiments were conducted between 09:00 AM and
2:00 PM. Behavior in all the tests was observed visually and
recorded by video camera. Observers were blind to the early-life
treatment of the animals. Each rat was taken randomly from
the cage and after the HP test was labeled with a picric acid
solution. Rats were returned to their home cage at the end of
each test.
Hot Plate (HP) Test
Baseline nociceptive sensitivity was assessed using the HP test.
The apparatus consists of a 25 cm × 25 cm metal HP surface set
at 51◦C, a Plexiglas cage that fits over the HP and a foot-switch
timer. A rat was taken randomly from the nest and placed on the
HP. Latency to the first lifting the paw is usually considered an
indication of pain threshold. We terminate the test if there is no
response during 30 s. The latency was averaged from three trials
with 10 min intervals between each trial. The testing apparatus
was thoroughly cleaned between trials.
Formalin Test
The formalin test is widely used to assess intensity of
inflammatory pain response to formalin injection. The response
(flexing and licking behaviors) consists of the acute and tonic
phases (Barrot, 2012). The test lasted 60 min. The first acute
phase lasts for about 5 min after the formalin injection and
is considered to arise from direct activation of myelinated
and unmyelinated nociceptive afferent fibers. The second tonic
phase (about 50 min) is considered to result from changes
in central nervous system (CNS) function induced by neural
activity generated during the first phase and from the developing
inflammation caused by the formalin during the second phase
(Coderre et al., 1993). We measured licking, mediated at the
supraspinal level, in response to formalin injection (2.5%,
50 µl into the pad of the left hind paw) during the acute
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and tonic phases (Butkevich I. et al., 2011) using a computer
program specially created for our experiments that allows
recording, quantification and analysis of the formalin-induced
pain behaviors.
Elevated Plus Maze (EPM)
The elevated plus maze is a widely used measure of anxiety
in rodents (Wall and Messier, 2001). The standard elevated
plus maze (two opposing open arms, 50 cm × 10 cm and two
other arms of the same size having 50 cm high transparent
Plexiglas walls; the maze is raised 100 cm above the floor) was
used to evaluate the anxiety level. During the 5-min test we
recorded the time spent in the open arms (s) and the number of
unprotected head dips which negatively correlate with the level
of anxiety.
Forced Swim Test (Modification of the
Porsolt Test) (Porsolt et al., 1977)
The forced swim test is one of the most widely used measures of
an animal’s ability to cope with stress. Each rat was individually
placed into the glass cylinder filled with water (diameter
25 cm, height 60 cm, 24 ± 1◦C). The time of immobility
(the rat only makes movements necessary to keep the head
above the water) was recorded during the 5-min test. This
parameter, characterizing the level of depression, is widely
considered a negative index of the animal’s ability to cope
with stress.
Statistical Analyses
For all analyses, we averaged the data from littermates (where
they were 2 or 3 from a litter) to create a single data point
per litter. Thus the unit of analysis was the litter. All data are
presented as mean ± SEM. We analyzed the data with either
a 3 × 2 × 2 ANOVA (the HP test, the forced swim test) or
3 × 2 × 2 MANOVA (the formalin test, elevated plus maze) to
test the effects of the different experimental conditions (Series
I without SAL and BUS; Series II with SAL; Series III with
BUS), Pain (CTL, FOR) and Stress (CTL, MI) on the following
indices: basal pain, licking duration (two phases), anxiety
(number of unprotected head dips and time spent in the open
arms), depression (time of immobility). Multiple comparisons
and simple effect tests were performed with Bonferroni’s test.
The partial eta square (η2) was used to estimate effect size.
P < 0.05 was considered statistically significant. Data analysis
was carried out with the SPSS Inc. software.
RESULTS
Hot Plate (HP) Test
For the HP latency there were main effects of Pain and Stress
(F(1,110) = 6.93, p = 0.010, η2 = 0.059 and F(1,110) = 6.52,
p = 0.012, η2 = 0.056, respectively) and a significant interaction
between Pain and Stress (F(1,110) = 9.7, p = 0.001, η2 = 0.081).
The neonatal inflammatory treatment produced bilateral basal
thermal hypoalgesia in the adult rats exposed to FOR on P1, 2.
Post hoc testing showed a significant increase of HP latency
in adult rats exposed to FOR on P1, 2 with respect to CTL
(naïve rats; p = 0.004) in the Series I. There were no significant
differences in the HP latency between CTL and other groups
(FOR, MI and FOR followed by MI) in Series II and Series III.
Chronic injection of adolescent buspirone (Series III) in the rats
exposed to FOR on P1, 2 decreased the HP latency as compared
to the HP latency in FOR rats with adolescent SAL (Series II;
p < 0.05). Adolescent BUS did not affect on paw withdrawal
latency in CTL rats (Figure 1).
Formalin Test
For licking duration there was a significant multivariate main
effect of Experimental Condition (Wilks’ λ = 0.923, F(4,214) = 2.2,
p = 0.07, η2 = 0.039) and a significant interaction between Pain
and Stress (Wilks’λ = 0.867, F(2,107) = 8.18, p< 0.001, η2 = 0.133).
In addition, the interaction between the Experimental Condition,
Pain and Stress was also significant (Wilks’ λ = 0.885,
F(4,214) = 3.63, p = 0.011, η2 = 0.059). Given the significance
of the overall test, the univariate main effects were examined.
There were significant univariate main effect of Experimental
Condition for licking duration for the second phase of the
formalin test only (F(2,108) = 4.0, p = 0.020, η2 = 0.07), and a
significant interaction between Pain and Stress (F(1,108) = 8.97,
p = 0.003, η2 = 0.077) and between the Experimental Condition,
Pain and Stress (F(2,108) = 5.73, p = 0.004, η2 = 0.096). There
were no significant influences of early-life treatments (FOR, MI,
FOR followed by MI) on licking duration in the first phase of
the formalin test for any Series, or any effect of adolescent BUS
(Series III) on licking duration as compared to the adolescent
SAL (Series II) in any groups (Figure 2A). In the second phase of
the formalin test, in Series I, post hoc testing showed an increase
FIGURE 1 | Effect of adolescent buspirone on paw withdrawal latency
in the hot plate (HP) test in adult rats exposed to different treatments
(FOR, MI, FOR followed by MI) on P1, 2. FOR, inflammatory pain induced
by injection of formalin (FOR group); MI, maternal deprivation-isolation (MI
group); FOR followed by MI, combination of inflammatory pain and maternal
deprivation-isolation (FOR followed by MI group). Series I: without adolescent
saline (SAL) and adolescent buspirone (BUS); Series II: with adolescent SAL;
Series III: with adolescent BUS. CTL, control group (naïve rats). SAL,
adolescent chronic injection of saline from P25 to P39 to rats in each group
(CTL, FOR, MI, FOR followed by MI); BUS, adolescent chronic injection of
buspirone from P25 to P39 to rats in each group (CTL, FOR, MI, FOR followed
by MI). Data are mean ± SEM.
Frontiers in Behavioral Neuroscience | www.frontiersin.org 4 January 2017 | Volume 11 | Article 11
Butkevich et al. Buspirone Reduces Consequences of Neonatal Insults
FIGURE 2 | Effect of adolescent buspirone on licking duration in the formalin test during the first phase (A) and the second phase (B) in adult rats
exposed to different treatments (FOR, MI, FOR followed by MI) on P1, 2. FOR, inflammatory pain induced by injection of formalin (FOR group); MI, maternal
deprivation-isolation (MI group); FOR followed by MI, combination of inflammatory pain and maternal deprivation-isolation (FOR followed by MI group). Series I:
without adolescent saline (SAL) and adolescent buspirone (BUS); Series II: with adolescent SAL; Series III: with adolescent BUS. CTL, control group (naïve rats). SAL,
adolescent chronic injection of saline from P25 to P39 to rats in each group (CTL, FOR, MI, FOR followed by MI); BUS, adolescent chronic injection of buspirone
from P25 to P39 to rats in each group (CTL, FOR, MI, FOR followed by MI). Data are mean ± SEM.
in licking duration during the second phase in adult rats exposed
to FOR or MI on P1, 2 (p = 0.046 and p = 0.004, respectively) as
compared to CTL (naïve rats; Figure 2B). Licking duration was
not altered in adult rats that had experienced the combination of
pain and stress on P1, 2; their licking duration was significantly
lower than in the MI group (p = 0.011; Figure 2B). In Series
II, chronic injection of SAL during the adolescence increased
licking duration in rats exposed to FOR on P1, 2 as compared
to CTL (p = 0.049), but was not changed in rats exposed to MI
and to FOR followed by MI. Licking duration in the latter was
significantly lower than in FOR animals (p = 0.018). In Series III,
there were no significant differences in licking duration between
CTL and other groups (FOR, MI and FOR followed by MI).
Chronic injection of adolescent buspirone in the rats exposed
to FOR as well as to MI on P1, 2 reduced licking duration
as compared to the effect of chronic injection of adolescent
SAL (Series II; p = 0.049 and p = 0.022 respectively) and
compared to Series I in the rats of similar groups (p = 0.046 and
p < 0.001 respectively). There was no effect of adolescent
buspirone on licking duration in rats in the group of FOR
followed by MI (Figure 2B).
Elevated Plus Maze (EPM)
The MANOVA for anxiety revealed a significant multivariate
main effect of Stress (Wilks’ λ = 0.949, F(2,109) = 2.95, p = 0.049,
η2 = 0.051), and a significant interaction between Experimental
Condition and Stress (Wilks’ λ = 0.905, F(4,218) = 2.8, p = 0.027,
η2 = 0.049) and between Pain and Stress (Wilks’ λ = 0.948,
F(2,109) = 2.99, p = 0.049, η2 = 0.052). Given the significance
of the overall test, the univariate main effects were examined.
There were significant univariate main effects of Stress for
Elevated plus maze (EPM) for the number of head dips
(F(1,110) = 5.7, p = 0.019, η2 = 0.049) and for an interaction
between Experimental Condition, Pain and Stress (F(2,110) = 4.10,
p = 0.019, η2 = 0.069). For the time spent in the open arms there
were significant interactions between Experimental Condition
and Stress (F(2,110) = 3.21, p = 0.044, η2 = 0.055), between Pain
and Stress (F(1,110) = 5.8, p = 0.017, η2 = 0.05) and between
the Experimental Condition, Pain and Stress (F(2,110) = 2.7,
p = 0.054, η2 = 0.047). In Series I, adult rats exposed to FOR
or MI on P1, 2 showed a decrease in the time spent in the
open arms (p = 0.049 and p = 0.006, respectively) and in the
number of unprotected head dips (p = 0.049 and p = 0.023)
as compared to CTL. The combination of FOR and MI on P1,
2 did not change these indices relative to CTL (Figures 3A,B).
In Series II, chronic injection of SAL during the adolescence
decreased the time spent in the open arms in rats exposed to
FOR and to MI on P1, 2 as compared to CTL (p = 0.015 and
p = 0.06 respectively), but not in rats exposed to FOR followed
by MI; there were also significant differences in the number of
head dips between CTL and other groups (FOR, MI and FOR
followed by MI). In Series III, there were no differences between
CTL and other groups (FOR, MI and FOR followed by MI) in
either the time spent in the open arms or in the number of
unprotected head dips. In both indices of anxiety there were
no significant differences between the effects of adolescent BUS
and SAL in any groups of rats. In Series III, chronic injection
of adolescent buspirone in the rats exposed to FOR and to
MI on P1, 2 increased the number of head dips as compared
to this index in the similar groups in Series I (p = 0.039 and
p = 0.049 respectively) and normalized the number of head dips
(Figure 3B).
Forced Swim Test
The ANOVA for immobility revealed significant main effects
of Experimental Condition, Pain and Stress (F(2,110) = 12.1,
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FIGURE 3 | Effect of adolescent buspirone on the indices of anxiety
(A, time spent on open arms, B, the number of head dips) in adult rats
exposed to different treatments (FOR, MI, FOR followed by MI) on P1, 2. FOR,
inflammatory pain induced by injection of formalin (FOR group); MI, maternal
deprivation-isolation (MI group); FOR followed by MI, combination of
inflammatory pain and maternal deprivation-isolation (FOR followed by MI
group). Series I: without adolescent saline (SAL) and adolescent buspirone
(BUS); Series II: with adolescent SAL; Series III: with adolescent BUS. CTL,
control group (naïve rats). SAL, adolescent chronic injection of saline from
P25 to P39 to rats in each group (CTL, FOR, MI, FOR followed by MI); BUS,
adolescent chronic injection of buspirone from P25 to P39 to rats in each
group (CTL, FOR, MI, FOR followed by MI). Data are mean ± SEM.
p < 0.001, η2 = 0.180, F(1,110) = 9.88, p = 0.002, η2 = 0.082 and
F(1,110) = 27.7, p < 0.001, η2 = 0.201, respectively) and
significant interactions between Experimental Condition and
Stress and between Pain and Stress (F(1,110) = 3.56, p = 0.032,
η2 = 0.061, F(1,110) = 13.99, p < 0.001, η2 = 0.113 respectively).
In Series I, adult rats exposed on P1, 2 to FOR, MI and FOR
followed by MI showed an increase in the time of immobility
(p < 0.001 in all cases) as compared to CTL (Figure 4).
In Series II, chronic injection of SAL during the adolescence
increased the time of immobility in rats exposed on P1, 2 to
FOR, MI and FOR followed by MI as compared to CTL
(p = 0.001, p < 0.001, p < 0.001, respectively). In Series
III, there were no differences between CTL and other groups
(FOR, MI and FOR followed by MI). In Series III, chronic
injection of adolescent buspirone in the rats exposed on P1,
2 to FOR, MI and FOR followed by MI decreased the time of
immobility as compared to these indices in the similar groups
FIGURE 4 | Effect of adolescent buspirone on the immobility time in
adult rats exposed to different treatments (FOR, MI, FOR followed by
MI) on P1, 2. FOR, inflammatory pain induced by injection of formalin (FOR
group); MI, maternal deprivation-isolation (MI group); FOR followed by MI,
combination of inflammatory pain and maternal deprivation-isolation (FOR
followed by MI group). Series I: without adolescent saline (SAL) and adolescent
buspirone (BUS); Series II: with adolescent SAL; Series III: with adolescent
BUS. CTL, control group (naïve rats). SAL, adolescent chronic injection of
saline from P25 to P39 to rats in each group (CTL, FOR, MI, FOR followed by
MI); BUS, adolescent chronic injection of buspirone from P25 to P39 to rats in
each group (CTL, FOR, MI, FOR followed by MI). Data are mean ± SEM.
in Series I (p = 0.019, p = 0.012, p = 0.055 respectively) and
in Series II (p = 0.046, p = 0.005, p < 0.001 respectively)
and normalized the time of immobility in all the groups
(Figure 4).
DISCUSSION
The present study demonstrates that repeated inflammatory
pain and stress in neonatal rats induce long-term alterations in
adaptive behaviors depending on the type of treatment. In the
adult rats exposed to inflammatory pain on P1, 2 there was a
general decreased pain sensitivity to thermal stimulation in the
HP test. In the formalin test, we found hyperalgesia in adult
rats that had experienced inflammatory pain or the ‘‘psychogenic
stress’’ of MI as neonates. The lack of long-term effects of
the combination of early pain and MI on pain sensitivity and
emotionality is of particular interest. The level of anxiety in the
adult rats depended on the type of early treatment; all rats showed
impaired stress coping ability irrespective of the type of neonatal
treatment. Our results provide the first evidence that chronic
injections of buspirone during the critical adolescent period
normalize basal pain and pain sensitivity in the formalin test and
the indices of psycho-emotional behavior in the adult rats that
demonstrated behavioral alterations induced by early-life adverse
treatments.
The data from the HP test in adult rats exposed to formalin
pain on P1, 2 are in agreement with literature data on hypoalgesia
in adult rats after inflammatory pain evoked during the neonatal
period by an injection of carrageenan (CAR) and complete
Freund’s adjuvant (CFA), agents with a more prolonged action
than formalin (Lidov, 2002). However, the data on influences of
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early-life formalin-induced pain are inconsistent. For instance,
early-life pain caused by formalin injection in rodents led to
hyperalgesia in later life (Mohamad et al., 2011) or had no
effect (Negrigo et al., 2011) in the HP test. The discrepancy
between the results with neonatal formalin pain can be explained
by the different concentration of formalin and the number of
injections, as well as by the age of the neonatal rats (the former
authors used 5%, 10 µl, once a day for the first three postnatal
days, while the latter used two unilateral plantar injections
of 4% formalin, 10 µl with an 1 h interval between them
on P1).
It was suggested that hypoalgesia results from upregulated
endogenous opioid tone in brain areas mediating pain (Laprairie
and Murphy, 2009; Victoria and Murphy, 2016). The opioidergic
system, as well as the monoaminergic system, is involved in the
descending inhibitory modulation of the nociceptive signals and
these systems can act together and independently (Hurley et al.,
2003). Hypoalgesia, which presents regardless of the segmental
level, is believed to be associated with more widespread
mechanisms beyond the somatotopically organized nociceptive
pathways of the dorsal horn, also involving the brainstem
descending pain control system and the HPA system (Anseloni
et al., 2005; Schwaller and Fitzgerald, 2014). However, the impact
of early injury on this temporally regulated descending control
of the developing and reorganizing dorsal horn requires further
investigation (Beggs, 2015; Walker et al., 2016). For the HPA axis
responses, a similar bi-directional effect was suggested (Victoria
et al., 2013).
In the formalin test, rats exposed to neonatal inflammatory
pain and immediately returned to the dam and the rats exposed
to MI before being returned to the dam displayed heightened
hyperalgesia as adults. Obviously, favorable factors like reunion
with the dam and siblings and the odor of the nest were
insufficient to suppress the consequences of differing adverse
events. An elevated level of corticosterone in response to adverse
experiences in newborn rat pups can influence the development
of the stress system and later lead to changes in the response
to formalin-induced pain. Indeed, literature data show that
early-life stress in rats decreases the nociceptive threshold
and enhances inflammatory mediator-induced hyperalgesia in
adults, and inflammatory pain experienced on the day of
birth alters adult responses to stress- and pain-provoking
stimuli and deregulates the HPA axis (Victoria and Murphy,
2016). Since we used short-term MI, we cannot compare
our results with the available literature data since only the
effects of much more prolonged maternal deprivation on
different types of behavior or HPA axis development have
been studied (Nishi et al., 2014). Therefore short (60 min)
isolation from the dam and siblings on P1 and repeatedly
on P2 increases inflammatory pain when the rats reach the
adulthood.
We obtained unexpected results regarding the pain response
of adult rats exposed to the combination of pain and MI. In these
adult rats, the formalin-induced pain response did not differ
from the control pain response; moreover, it was significantly
lower than the pain response in adult rats with the other
neonatal treatments. It is also surprising that the combination
of pain and stress on P1, 2, when the HPA axis still actively
responds to irritants, failed to alter the pain sensitivity in the
adult rats. Our results suggest that neonatal injury-induced
changes evoked within the CNS by the interaction between
the HPA axis and the nociceptive system in the neonatal rats
exposed to FOR followed by MI contribute to the response to
re-inflammation when these animals are adults. The functional
activity of the HPA axis in 1–2-day-old rat pups is still high,
since the so-called stress hyporesponsive period (SHRP; Levine,
1994) begins on postnatal day 4, when rat pups have low basal
corticosterone levels and the corticosterone response to stressors
is blunted. Indeed, we previously demonstrated that neonatal
male rats exposed to formalin followed by maternal isolation had
increased plasma corticosterone levels as the formalin-induced
pain progressed during a 1-h period; the higher corticosterone
levels persisted the next day (Butkevich et al., 2013). Other
authors reported that plasma corticosterone levels were elevated
in P1 rat pups after pain evoked by CFA injection and remained
high for at least 1 week post-inflammatory injury (Victoria et al.,
2014).
Pain and stress in newborn rat pups may alter characteristics
of the nociceptive system and HPA axis development. In
newborn rats, the nociceptive system, in which 5-HT1A
receptors are important for the structural and functional
development of neural circuits, shows high sensitivity to painful
stimuli (Barr, 1998; Fitzgerald, 2005; Barr and Hunter, 2014).
This is due to several major factors such as immaturity of
C-fibers and the dominant role of low-threshold A-fibers in
nociception (Beggs et al., 2002), transient excitatory gamma-
aminobutyric acid (GABA) function at the spinal and supraspinal
levels (Hatfield, 2014), and immaturity of the descending
monoaminergic system (Butkevich I. P. et al., 2011). Early-life
adverse effects at the peripheral and central levels alter the
structural and functional development of the afferent fibers and
their relationships (Beggs, 2015).
Anxiety-like behavior, measured as the time spent in the
open arms of the EPM and the number of unprotected head
dipping, was significantly increased in adult rats that had
experienced inflammatory pain or MI as neonates. Interestingly,
the same rats showed heightened hyperalgesia in the formalin
test. When comparing the EPM and formalin test results, it
is reasonable to suggest that the heightened level of anxiety
and increased pain sensitivity shown by the various indices of
adaptive behavior in the adult rats exposed to both early-life
pain and stress are interrelated. The literature reports multi-
faceted effects of early-life pain on anxiety-like behavior. For
instance, newborn rats injected with CAR in the first postnatal
week displayed reduced anxiety-like behavior as adults, thought
to be due to increased activity of the opioid system (Anseloni
et al., 2005; Victoria et al., 2014). In contrast, early-life hind-paw
inflammation with formalin failed to alter anxiety in this test
in male rats (Negrigo et al., 2011). Importantly, the markedly
increased level of anxiety in our rats with early-life pain or
stress contrasted with the lack of long-term changes in the
anxiety indices in the rats with the combination of early-life
pain and stress. The latter did not show also any changes
in the formalin-induced pain response. These interesting data
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on unusual consequences of the combination of early-life
pain and stress on the development of adaptive behavior
and nociception are worthy of particular attention. In the
forced swim test, all infant treatments altered the depression
phenotype. However other authors found that CAR-induced
acute peripheral inflammation on P3 significantly decreased
adult depression-related behaviors in the forced swim test
(Anseloni et al., 2005). Differences in the experimental designs
may contribute to the discrepancies between our results and the
results of these authors.
Of particular interest is the behavior of the adult rats with
the combination of early-life pain and stress. The behaviors
in the HP test, formalin test and EPM in the rats of this
group were unchanged, whereas the index of depression
was significantly increased. This replicates our prior work
showing that the combination of neonatal pain and stress in
conditions of re-inflammation had no effect in adolescent rats
(Butkevich et al., 2015). The means, by which there was a lower
pain response in adult animals with greater overall neonatal
adversity, are unknown but it is an important question in
understanding the long-term effects of early pain and stress
on adaptive behavior. Although definite mechanisms of adverse
influences in early life on nociceptive pathways are not known,
they could be mediated by the HPA axis, which affects the
brainstem descending pain control systems and thus influences
neurophysiological mechanisms underlying pain perception
(Schwaller and Fitzgerald, 2014).
We also provide the first evidence that chronic injection of
buspirone in adolescent rats exposed to early-life peripheral
inflammatory pain or short-lasting MI normalized pain
sensitivity and the level of depression and improved the level
of anxiety when the rats were adults. Importantly, buspirone
had antinociceptive, antidepressive and anxiolytic effects only
in the adult rats that showed long-term behavioral alterations
induced by early-life adverse injury. In adult rats with the
combination of early-life pain and stress, buspirone had an effect
only in the forced swim test, during which these rats showed
heightened depression without buspirone injections, but not
in the other tests, in which behavior was unchanged. There
are clinical observations that buspirone affects patients with
symptoms of anxiety and depression but not healthy patients.
Our data on the effects of buspirone on both inflammatory
pain and psychoemotional behavior in adult rats suggest that
because buspirone is a full agonist of presynaptic 5-HT1A
receptors and a partial agonist of postsynaptic 5-HT1A
receptors (Albert and François, 2010; Albert and Fiori, 2014),
it decreases pain sensitivity via 5-HT1A receptors in the
descending monoaminergic inhibitory system (Butkevich I. P.
et al., 2011). The 5-HT1A receptor plays an important role
in neuronal development and plasticity (Whitaker-Azmitia
et al., 1996). It is the main receptor in autoregulation of the
brain 5-HT system (Samuels et al., 2016). In the spinal cord
and brain, the 5-HT1A receptor is involved in nociceptive
mechanisms (Colpaert, 2006) and mediates an inhibitory effect
of the descending serotonergic system on inflammatory pain
behavior (Millan, 1999). 5-HT1A receptors are implicated
also in mood disorders (anxiety, depression; Popova and
Naumenko, 2013). The other possibility is that buspirone,
acting via 5-HT1A receptors during the adolescent period, can
eliminate abnormalities in the CNS evoked by impairment
of close interactions between the 5-HTergic system and the
HPA axis. The 5-HTergic system and the HPA axis act jointly
especially in brain regions involved in the neurobiological
substrate of stressful and painful responses, such as the
hippocampus and hypothalamus (Belay et al., 2011). Our
previous data indicate that prenatal buspirone increases the
plasma level of corticosterone in prenatally stressed rats during
formalin-induced pain (Butkevich et al., 2013). Buspirone in
early adolescent period activating the HPA axis via 5-HT1A
receptors could lead to facilitation of some adaptive mechanisms
disturbed by early adverse insults. The adolescent period is
characterized with heightened neurodevelopmental plasticity,
which provides opportunities to re-direct programming
stemming from neonatal life experiences (McCormick and
Green, 2013).
Previously we found in 25-day-old rats morphological
abnormalities in the nucleus raphe magnus following neonatal
inflammatory pain that heightened hyperalgesia in the formalin
test; structural characteristics were improved by chronic
injections of buspirone and pain sensitivity was normalized
when the rats reached late adolescence (Butkevich et al.,
2015; Droblenkov et al., 2015). This nucleus is involved
in the descending serotonergic system, which modulates
nociceptive signals at the spinal cord dorsal horns and has
neuroanatomical connections with the prefrontal cortex
(Bernasconi et al., 2015) involved in psycho-emotional
behavior. Morphofunctional alterations in the cortex and
hippocampus were found in adult rodents that had suffered
early repeated pain injuries (Malheiros et al., 2014). At present
we cannot know which type of 5-HT1A receptors is involved
in effects of buspirone. There are different views on the
involvement of pre- and postsynaptic 5-HT1A receptors
in the anxiolytic and antidepressant effects of buspirone.
A recent study using a genetic system to independently
decrease levels of the 5-HT1A auto- and heteroreceptor
population (Richardson-Jones et al., 2011) demonstrated
that 5-HT1A autoreceptors affect anxiety-like behavior while
5-HT1A heteroreceptors affect behavioral despair responses.
Buspirone as an antidepressant drug may increase 5-HT-
ergic signaling at the postsynaptic receptor either through
desensitization of the somatodendritic autoreceptors or through
enhanced activation of G proteins at the postsynaptic 5-HT1A
receptors.
In summary, our studies using the model of early-life
pain/stress in P1, 2 rats for investigation of long-term effects
of adverse injuries and adolescent buspirone injections on
adaptive behavior in the adult male rats have demonstrated that
alterations in the behavioral responses are differently influenced
by the type of injury. Of particular interest is the lack of
long-term effects of the combination of early pain and stress of
short MI on basal pain, formalin-induced pain responses and
anxiety. We provide the first evidence that chronic injection
of buspirone during the critical adolescent period induces
antinociceptive, antidepressive and anxiolytic effects only in
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those adult rats that showed behavioral alterations induced by
early-life adverse experiences. The data highlight the role of
5-HT1A receptors in long-term effects of neonatal inflammatory
pain and stress of short MI on adaptive behavior and indicate
possibility of correction of the pain and psychoemotional
behavior altered by adverse pain/stress intervention using
buspirone during critical adolescent period. Further studies
should be devoted to studying this problem in female rats with
the aim to find sexual dimorphism in effects of adolescent
buspirone on long-term influence of neonatal pain and stress
injuries.
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